-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

613. Acute Myeloid Leukemia: Clinical Studies: Poster III

Acute Myeloid Leukemia: Clinical Studies Program: Oral and Poster Abstracts
Type: Poster
Monday, December 7, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Arnaud Pigneux1,2,3*, Christian Recher, MD-Ph.D.4, Marie C Bene, PharmSciD, PhD5*, Julien Asselineau, PhD6*, Ariane C. Mineur7*, Thibaut Leguay, MD8*, Jacques Delaunay, MD9*, Caroline Bonmati, MD10*, Romain Guieze, MD11*, Isabelle Luquet, MD12*, Pascale Cornillet-Lefebvre, MD13*, Catherine Lacombe, MD, PhD14, jean-Christophe Ianotto, MD15*, Mario Ojeda, MD16*, Mathilde Hunault, MD, PhD17*, Anne Banos, MD18*, Bruno Lioure, MD19*, Marc Bernard, MD20*, Eric Jourdan21*, Norbert Vey22, Hacene Zerazhi, MD23*, Hichri Yosr, MD24*, Roselyne Delepine25*, Rachid Salmi, MD, PhD6*, Francois Dreyfus, MD26*, Jean-Yves Cahn27 and Norbert Ifrah, MD, PhD28

1Hematology, Hôpital Haut Lêveque, Pessac, France
2INSERM UMR 1035, Bordeaux University, Bordeaux, France
3Hôpital Haut Lévêque-CHU de Bordeaux, Pessac, France
4Institut Universitaire du Cancer de Toulouse, Toulouse, France
5Hopital Hotel Dieu, Laboratoire d'Hematologie, Nantes, France
6CHU Bordeaux, Unité de Soutien Méthodologique à la Recherche Clinique (USMR), CHU Bordeaux Pôle de Santé Publique, place Amélie Rabat-Leon,, Bordeaux, France
7Service d’Hematologie Clinique et Therapie Cellulaire, CHU de Bordeaux, Pessac, France
8CHU Bordeaux Haut Lévêque, Service d’Hématologie Clinique et Thérapie Cellulaire, Pessac, France
9Department of Hematology, Nantes University Hospital, Nantes, France
10CHU Nancy, Nancy, France
11Clinical Hematology, CHU Clermont-Ferrand, Clermont Ferrand, France
12CHU Toulouse, Toulouse, France
13CHU Reims, reims, France
14Institut Cochin, INSERM U1016, Paris, France
15Hematology department, institute of oncology and Hematology, Morvan Hospital, CHRU Brest, Brest, France
16Service d'Hématologie Clinique et Unité de Thérapie Cellulaire, GHR MSA, Mulhouse, France
17CHU Angers, Hematology, Angers, France
18Hematology Department, CH Cote basque, Bayonne, France
19Department of Hematology and Oncology, CHU Hautepierre, Strasbourg, France
20CHU Rennes, Hematology, Rennes, France
21CHU Nimes, nimes, France
22Hematology, Institut Paoli-Calmettes, Marseille, France
23hematology, CHG Avignon, Avignon, France
24CHU, Hematology, Montpellier, France
25CHU Bretonneau, Tours, France
26CHU Cochin, Hematology, Paris, France
27Clinique Universitaire d'Hématologie, Grenoble University Hospital, Grenoble, France
28Hematology Department, University Hospital, Angers, France

S. Tiong Ong, MD1, Thushangi Pathiraja, PhD2*, Asif Javed, PhD3*, Xin Xuan Sheila Soh4*, Simeen Malik, PhD4*, Joanna H.J. Tan2*, Tun Kiat Ko, PhD4*, Charles Chuah4,5,6,7, Naoto Takahashi, M.D., Ph.D.8, Ravi Bhatia, MD9, King Pan Ng, PhD4*, Wee Joo Chng, MD, PhD10, Chandana Tennakoon, PhD3*, Qiangze Hoi3*, Peiyong Guan3*, Audrey S.M. Teo2*, Wah Heng Lee, PhD3*, Patrick Tan, MD, PhD11*, Win Kin Sung, PhD3*, Pauline Ng, PhD3* and Axel Hillmer, PhD2*

1Cancer and stem cell biology, Duke-NUS Graduate Medical school, Singapore, Singapore
2Cancer Therapeutics & Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore
3Computational & Systems Biology, Genome Institute of Singapore, Singapore, Singapore
4Cancer & Stem Cell Biology Signature Research Program, Duke-NUS Graduate Medical School, Singapore, Singapore
5Department of Hematology, Singapore General Hospital, Singapore, Singapore
6Singapore General Hospital, Duke-NUS Graduate Medical School, Singapore, Singapore
7Department of Haematology, Singapore General Hospital, Singapore, Singapore
8Department of Hematology, Nephrology and Rheumatology, Akita University, Akita, Japan
9Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
10Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
11Program in Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore, Singapore

Akihisa Sawada, PhD, MD1*, Sadao Tokimasa, PhD, MD2*, Masahiro Yasui, MD2, Maho Koyama-Sato, PhD, MD2*, Mariko Shimizu, MD2*, Kohei Higuchi, MD3*, Azusa Mayumi, MD2*, Aya Ioi, MD2*, Keisei Kawa, PhD, MD2* and Masami Inoue, MD1

1Department of Hematology/Oncology, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi, Japan
2Department of Hematology/Oncology, Osaka Medical Center and Research Institute for Maternal Child Health, Izumi, Japan
3Department of Hematology/Oncology, Osaka Medical Center and Research Institute For Maternal and Child Health, Izumi, Japan

Annie Im, MD1, Mounzer Agha, MD2, Anastasios Raptis, MD, PhD3, Jing-Zhou Hou, MD, PhD2, Rafic Farah, MD2, Seah H. Lim, MD, PhD, FRCP, FRCPath, MBBS2*, Robert Redner, MD2, Alison R. Sehgal, MD2, Kathleen A. Dorritie, MD2, Ann Welsh, RN, BSN, OCN2*, Linda Fukas, RN2*, Christine Tripoli, RN, BSN2*, Daniel Normolle, PhD4*, Daniel E Johnson, PhD5 and Michael Boyiadzis, MD, MHSc2

1Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA
2University of Pittsburgh Medical Center, Pittsburgh, PA
3UPMC Cancer Center, Pittsburgh, PA
4University of Pittsburgh, Pittsburgh, PA
5Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA

Patrizia Zappasodi, MD1*, Laura Marbello, MD2*, Erika Borlenghi, MD3*, Monica Fumagalli, MD4*, Massimo Bernardi, MD5*, Nicola Stefano Fracchiolla, MD6*, Matteo Da Vià, MD1*, Marianna Rossi, MD1*, Emanuele Ravano, MD7*, Elisa Cerqui, MD3*, Virginia Valeria Ferretti, PhD8*, Mario Cazzola, Prof1, Carlo Castagnola, MD1* and Giuseppe Rossi, MD9

1Department of Hematology, Foundation, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
2Department of Hematology and Oncology, A.O. Ospedale Niguarda Cà Granda, Milan, Italy
3Department of Hematology, A.O. Spedali Civili of Brescia, Brescia, Italy
4Department of Hematology, Ospedale San Gerardo, Monza, Italy
5Hematology and Bone Marrow Transplantation Unit, San Raffaele Hospital Scientific Institute, Milan, Italy
6Oncohematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
7Department of Hematology, Niguarda Ca' Granda Hospital, Milano, Italy
8Department of Hematology and Oncology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
9Department of Hematology, Spedali Civili di Brescia, Brescia, Italy

Ursula Creutzig, MD1*, Claudia Rossig, MD2, Michael Dworzak, MD3*, Arendt von Stackelberg, MD4, Wilhelm Woessmann, MD5*, Jan Stary6, Martin Zimmermann, PhD7* and Dirk Reinhardt, MD8

1Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany
2Pediatric Hematology and Oncology, University Childrens Hospital Muenster, Muenster, Germany
3Department of Pediatrics, Medical University of Vienna, St. Anna Children's Hospital and Children’s Cancer Research Institute, Vienna, Austria
4Dept. of Pediatric Oncology/Hematology, Charité University Medical Center Berlin, Berlin, Germany
5Department of Pediatric Hematology and Oncology, Justus-Liebig-University, Giessen, Giessen, Germany
6CLIP- Childhood Leukaemia Investigation Prague, Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
7Department of Pediatric Hematology/Oncology, Hannover Medical School, Hannover, Germany
8AML-BFM Study Group, Pediatric Hematology/Oncology, University Children’s Hospital Essen, Essen, Germany

Lisa Pleyer, MD, DI1*, Sonja Burgstaller, MD2*, Reinhard Stauder, MD, MSc3*, Michael Girschikofsky, MD4*, Heinz Sill, MD5, Konstantin Schlick, MD1*, Josef Thaler, MD2*, Britta Halter, MSc3*, Sigrid Machherndl-Spandl, MD4, Armin Zebisch, MD5*, Angelika Pichler, MD6*, Michael Pfeilstöcker, MD7, Eva-Maria Autzinger, MD8*, Alois Lang, MD9*, Klaus Geissler, MD10*, Daniela Voskova, MD11*, Dietmar Geissler, MD12*, Wolfgang R Sperr, MD13*, Sabine Hojas, MD14*, Inga Mandac Rogulj, MD15*, Johannes Andel, MD16* and Richard Greil, MD1

13rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Hospital Salzburg, and Center for Clinical Cancer and Immunology Trials at Salzburg Cancer Research Institute, Salzburg, Austria
2Department of Internal Medicine IV, Klinikum Wels-Grieskirchen, Wels, Austria
3Department of Internal Medicine V, Innsbruck Medical University, Innsbruck, Austria
4Department of Hematology and Oncology, Elisabethinen Hospital, Linz, Austria
5Department of Hematology, Medical University of Graz, Graz, Austria
6Department for Hematology and Oncology, LKH Leoben, Leoben, Austria
73rd Medical Department for Hematology and Oncology, Hanusch Hospital, Vienna, Austria
8First Medical Department, Center for Oncology, Hematology and Palliative Care, Wilhelminenspital, Vienna, Austria
9Department of Internal Medicine, LKH Feldkirch, Feldkirch, Austria
105th Medical Department, Hospital Hietzing, Vienna, Austria
11Department of Internal Medicine III, General Hospital, Linz, Austria
121. Medical department, Klinikum Klagenfurt, Klagenfurt, Austria
13Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria
14Department of Internal Medicine, LKH Fürstenfeld, Fürstenfeld, Austria
15Department of Hematology, Clinical Hospital Merkur, Zagreb, Croatia
16Department of Internal Medicine II, LKH Steyr, Steyr, Austria

Ahmed Aribi, MD1, Cedric Dos Santos, Ph.D2*, Margaret O' Donnell, MD1*, Anthony S. Stein, MD1, Allen Lin1*, Joycelynne M. Palmer, PhD1*, Meng Zhuo1*, David Snyder, MD1*, Haris Ali, MD1*, Robert Chen1, Leslie L. Popplewell, MD1, Nitya Nathwani, MD1, Samer K Khaled, MD1, Amandeep Salhotra, MD1*, Alex Herrera, MD1*, Ibrahim Aldoss, MD1, Eileen P. Smith, MD1, Guido Marcucci, MD1, Stephen J. Forman, MD1 and Ravi Bhatia, MD3*

1City of Hope, Duarte, CA
2Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
3University of Alabama Birmingham, Birmingham, AL

Richard F. Schlenk, M.D.1, Hartmut Döhner, Prof. MD2, Konstanze Döhner, MD1, Arnold Ganser3, Michael Heuser, MD4, Axel Benner5*, Marc E. Buyse, ScD6* and Tomasz Burzykowski, PhD6*

1Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
2Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
3Dept. Hem/Onc & Transplantation, Hannover Medical School, Hannover, Germany
4Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
5German Cancer Research Center, Heidelberg, Germany
6IDDI and Hasselt University, Louvain-la-Neuve, Belgium

Ditte Juel Adolfsen Løhmann, MD1*, Jonas Abrahamson2*, Shau Yin Ha3, Ólafur G. Jónsson4*, Minna Koskenvuo5*, Birgitte Lausen, MD6, Josefine Palle7*, Bernward Zeller8* and Henrik Hasle, MD, PhD9

1Department of Pediatrics, Aarhus University Hospital, Aarhus N, Denmark
2Institution for Clinical Sciences, Department of Pediatrics, Queen Silvia Children’s Hospital, Gothenburg, Sweden
3Dept. of Pediatrics and Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China
4Department of Pediatrics, Landspitalinn, Reykjavik, Iceland
5Division of Hematology-Oncology and Stem Cell Transplantation, Children’s' Hospital and Helsinki University Central Hospital, Helsinki, Finland
6Department of Pediatrics, Rigshospitalet, Copenhagen, Denmark
7Department of Woman´s and Children´s Health, Uppsala University, Uppsala, Sweden
8Department of Pediatric Medicine, Oslo University Hospital, Oslo, Norway
9Department of Pediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark

Naveen Pemmaraju, MD1, Hagop M. Kantarjian, MD2, Jorge E. Cortes, MD3, Madeleine Duvic, MD4, Joseph D Khoury, MD5, Keyur Patel, MD5*, Naval Daver, MD6, Susan O'Brien, MD7, Sherry Pierce, BSN, BA2*, Guillermo Garcia-Manero, MD3, Elias Jabbour2, Nitin Jain, MD2, Stefan Faderl, MD8, Deborah Thomas, MD9*, Arthur E. Frankel, MD10, Muzaffar H. Qazilbash, MD11 and Marina Konopleva, MD, PhD12

1Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
4Dept. of Dermatology, M.D. Anderson Cancer Center, Houston, TX
5Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, Houston, TX
7Department of Leukemia, The University of Texas MD Anderson Cancer Center,, Houston, TX
8Department of Leukemia, The University of Texas, MD Anderson Cancer Center, Houston, TX
9Leukemia, MD Anderson Cancer Center, Houston, TX
10University of Texas Southwestern Medical Center, Dallas, TX
11Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
12Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Aref Al-Kali, MD1, Raoul Tibes, MD, PhD2, James M. Foran, MD3, Mrinal M Patnaik, MBBS1, Naseema Gangat, MBBS1, Adam C Bartley, MS4*, Michelle Elliott, MD1*, Mark R Litzow, MD1 and Ronald S. Go, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of Hematology and Medical Oncology, Mayo Clinic, Scottsdale, AZ
3Mayo Clinic Cancer Center, Jacksonville, FL
4Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN

Stefan Deneberg, M.D., Ph.D.1,2*, Ebba Lundin1*, Vladimir Lazarevic3*, Lina Benson4*, Bertil Uggla, MD PhD5*, Petar Antunovic, MD6*, Lars Mollgard7*, Sören Lehmann, Prof8, Gunnar Juliusson, M.D, Ph.D.3, Martin Höglund, Ass Prof9* and Asa Rangert Derolf, MD PhD10*

1Center of Hematology, Karolinska University Hospital, Stockholm, Sweden
2Institution of medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden
3Department of Hematology, Skåne University Hospital, Lund, Sweden
4Dept Clinical Science & Education, Karolinska Institutet, Stockholm, Sweden
5Medicine, Örebro University Hospital, Örebro, Sweden
6Hematology, University Hospital Linkoping, Linkoping, Sweden
7Dept of hematology, Sahlgrenska University Hospital, Gothenbourg, Sweden
8Hematology, Uppsala University, Uppsala, Sweden
9Hematology, Uppsala University Hospital, Uppsala, Sweden
10Department of Medicine, Division of Hematology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden

Kristian L Juul-Dam, MD1*, Charlotte G Nyvold, PhD2*, Hans B Ommen, MD, PhD2*, Olafur G Jonsson, MD3*, Birgitte Lausen, MD4, Kirsi Jahnukainen, MD, PhD5* and Henrik Hasle, MD1

1Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark
2Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
3Department of Paediatrics, Landspitalinn, Reykjavik, Iceland
4Department of Pediatrics, Rigshospitalet, Copenhagen, Denmark
5Children and Adolescents, Helsinki University Hospital, Helsinki, Finland

Bryan Brinda, Pharm.D.1*, Viet Q. Ho, PharmD, RPh, BCOP2*, Timothy George, Pharm.D., BCOP1*, Jeffrey E Lancet, MD1 and Rami S. Komrokji, MD1

1Moffitt Cancer Center, Tampa, FL
2Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL

Jasmine Noetzli1*, Sophie Voruz2*, Dorothea Wunder2*, Marie-Pierre Primi2*, Laura Crosazzo2*, Mathilde Gavillet, MD, PhD2*, Olivier Spertini3 and Sabine Blum4*

1Haematology Serive, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
2Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
3Hematology, CHUV, Lausanne, Switzerland
4Haematology Service, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

Jacob Lowell Glass, MD, PhD1, Ashwin Kishtagari, MD2,3*, Dan Douer, MD4 and Martin S Tallman, MD3

1Memorial Sloan Kettering, New York, NY
2Department of Medicine, Mt. Sinai St. Luke's Roosevelt Hospital, New York, NY
3Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Tao Zou, MD, PhD1*, Ashley M. Perry, BS1*, Andrew M. Brunner, MD1,2, Chepsy C Philip, DM3*, Donna S. Neuberg, Sc.D.4 and Amir T. Fathi, MD5

1Massachusetts General Hospital, Boston, MA
2Dana-Farber Cancer Institute, Boston, MA
3Department of Clinical Haematology, Haemato-Oncology & Bone Marrow (Stem cell) Transplantation, Christian Medical College, Ludhiana, India
4Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
5Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA

John F. Seymour, MBBS, PhD1, Lewis R. Silverman, MD2, Hartmut Döhner, Prof. MD3, Pierre Fenaux, MD, PhD4, Ghulam J. Mufti, MD, PhD5*, Valeria Santini, MD6, Mark D. Minden, MD, PhD7, Richard M. Stone, MD8, Lela M. Lucy, PhD9*, Stephen Songer, PharmD9*, Donna Dougherty, BSN9*, Randy Hinkle, RPh, MBA9*, Dominique Gambini, MD9*, C.L. Beach, PharmD9 and Hervé Dombret10

1Peter MacCallum Cancer Centre, Melbourne, Australia
2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
3Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany
4University Paris 7 Diderot, Hôpital Saint-Louis, Paris, France
5Department of Haematological Medicine, King's College Hosptial, London, United Kingdom
6AOU Careggi, University of Florence, Florence, Italy
7Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
8Dana-Farber Cancer Institute, Boston, MA
9Celgene Corporation, Summit, NJ
10Hematology, Hôpital Saint-Louis, Paris, France

Afshan Idrees, MD1*, Xiaohui Zhang, MD, PhD1,2*, Reza Setoodeh, MD1,3*, Samir Dalia, MD4, Ling Zhang, MD1,5 and Lubomir Sokol, M.D, Ph.D.6

1University of South Florida College of Medicine, Tampa, FL
2Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3James A Haley Veterans Hospital, Tampa, FL
4Mercy Clinic Oncology and Hematology, Joplin, MO
5Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
6Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Koji Sasaki, MD1, Hagop M. Kantarjian, MD2, Raja Luthra, PhD3*, Keyur P. Patel, MD, PhD3*, Guillermo Garcia-Manero, MD2, Srdan Verstovsek, MD, PhD2, Elihu H. Estey, MD2, Tapan Kadia, MD2, Mark Brandt, BS4*, Sherry Pierce, BSN, BA2*, Zeev Estrov, MD2, Alessandra Ferrajoli, MD2, Gautam Borthakur, MD2, Jorge E. Cortes, MD2 and Farhad Ravandi, MD2

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Enrico Maria Trecarichi, MD1*, Mario Tumbarello, MD1*, Roberta Di Blasi, MD2*, Luana Fianchi3*, Simona Sica3*, Bruno Martino, MD4*, Anna Candoni, MD5*, Gianpaolo Nadali, MD6, Domenico Pastore7*, Vincenzo Perriello, MD8*, Alessandro Busca, MD9, Franco Aversa, MD10*, Rosa Fanci, MD11*, Lorella Melillo, MD12*, Federica Lessi, MD13*, Maria Ilaria Del Principe, MD14*, Chiara Cattaneo15* and Livio Pagano3*

1Institute of Infectious Diseases, Catholic University of Sacred Heart, Rome, Italy
2Institute of Hematology, Catholic University of Sacred Heart, Rome, Italy
3Institute of Hematology, Catholic University, Rome, Italy
4Hamatology Dept., Ospedali Riuniti Bianchi Melacrino Morelli, Reggio Calabria, Italy
5Hematology, Santa Maria della Misericordia University Hospital, Udine, Italy
6Hematology, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy
7Hematology - Dept. of Emergency and Organ Transplantation, University of Bari, Bari, Italy
8University of Perugia, Institute of Hematology, S. Maria della Misericordia Hospital, Perugia, Italy
9Bone Marrow Transplantation Unit, University of Torino, Torino, Italy
10Hematology, Azienda Ospedaliero-Universitaria di Parma, Parma, Italy
11Hematology Unit, Careggi Hospital and University of Firenze, Firenze, Italy
12Department of Hematology and Stem Cell Transplant Unit, IRCCS, San Giovanni Rotondo, Italy
13Department of Medicine, Haematology Unit, University of Padova, Padova, Italy
14Hematology, University Tor Vergata, Rome, Italy
15Hematology, Spedali Civili, Brescia, Brescia, Italy

Sachin David, MSc1*, Vandana Kamath, MD2*, Uday Kulkarni, MD1*, Ramya Vijayan, Msc2*, Anu Korula, MD, DM1*, Fouzia NA, Dip NB, DM,1*, Nisham PN, DM1*, Alok Srivastava, MD1, Kavitha M Lakshmi, MSc1*, Poonkuzhali Balasubramanian, M.Sc., Ph.D1, Biju George, DM1, Sukesh Nair, M.B.B.S, DCP, DNB, FRCPA2* and Vikram Mathews, DM1

1Department of Haematology, Christian Medical College, Vellore, India
2Department of Transfusion Medicine and Immunohaematology, Christian Medical College, Vellore, India

*signifies non-member of ASH